果冻传媒

ShanX Medtech, a Dutch In-Vitro Diagnostics developer for clinical microbiology testing. The company was founded with a mission to change the status quo in bacterial infection management. The team recognized a critical gap in healthcare: doctors lacked quick, accurate tools to prescribe the right antibiotics, leading to ineffective treatments and the rise of antimicrobial resistance.

ShanX is developing innovative Antibiotic Susceptibility Testing devices that make advanced testing accessible across all healthcare settings. By providing real-time results, ShanX empowers healthcare professionals to prescribe the optimal antibiotic treatment, improving patient outcomes and combating resistance. Their technology is transforming how bacterial infections are diagnosed and treated, saving lives and making a global impact.